More Results

    Are you sure you want to change languages?

    The page you are visiting uses a different locale than your saved profile. Do you want to change your locale?

    From Sectors and Smart Beta to Fixed Income, SPDR Exchange Traded Funds (ETFs) give you wide access to diverse investment opportunities. Find out more.

    Okay

    From 9 march 2021, the TER on this fund will be reduced to 0.23%. Please refer to the shareholder notice issued on 2 march 2021.

    SPDR® MSCI Europe Health Care UCITS ETF STW FP

    Important Risk Disclosure

    Equity securities may fluctuate in value in response to the activities of individual companies and general market and economic conditions.

    ETFs trade like stocks, are subject to investment risk, fluctuate in market value and may trade at prices above or below the ETFs net asset value. Brokerage commissions and ETF expenses will reduce returns.

    Investing in foreign domiciled securities may involve risk of capital loss from unfavorable fluctuation in currency values, withholding taxes, from differences in generally accepted accounting principles or from economic or political instability in other nations.

    NAV EUR (Official NAV)

    €161,68

    as of 16 Apr 2021

    Base Fund Currency

    EUR

    1 Day Nav Change

    +€0,68 (+0,42%)

    as of 16 Apr 2021

    Assets Under Management

    €444,21 M

    as of 16 Apr 2021

    TER

    0,23%

    Quick Links

    Fund Objective

    Fund Objective

    The investment objective of the Fund is to track the performance of European large and mid-sized companies in the Health Care sector.

    Index Description

    Index Description

    The MSCI Europe Health Care 35/20 Capped Index is a free float-adjusted market capitalization weighted index that is designed to measure the equity market performance of constituents classified as Health Care (according to the Global Industry Classification Standard) in the MSCI Europe index.

    Fund Information as of 16 Apr 2021

    Fund Information as of 16 Apr 2021
    ISIN iNAV Ticker

    *These ticker codes are representative of the primary listing exchange.

    		 Inception Date Countries of Registration Base Fund Currency Income Treatment Settlement Cycle
    IE00BKWQ0H23 INSTW 05 Dec 2014 Austria, Denmark, Finland, France, Germany, Ireland, Italy, Luxembourg, Netherlands, Norway, Spain, Sweden, Switzerland, United Kingdom EUR Accumulation Redemption Settlement Cycle, DD+2; Subscription Settlement Cycle, DD+2
    ISIN IE00BKWQ0H23
    iNAV Ticker

    *These ticker codes are representative of the primary listing exchange.

    		 INSTW
    Inception Date 05 Dec 2014
    Countries of Registration Austria, Denmark, Finland, France, Germany, Ireland, Italy, Luxembourg, Netherlands, Norway, Spain, Sweden, Switzerland, United Kingdom
    Base Fund Currency EUR
    Income Treatment Accumulation
    Settlement Cycle Redemption Settlement Cycle, DD+2; Subscription Settlement Cycle, DD+2
    Trading Cycle TER Benchmark Minimum Investment Trading Currency UCITS Compliant Domicile
    DD 0,23% MSCI Europe Health Care 35/20 Capped Index 1 Share EUR, CHF, MXN Yes Ireland
    Trading Cycle DD
    TER 0,23%
    Benchmark MSCI Europe Health Care 35/20 Capped Index
    Minimum Investment 1 Share
    Trading Currency EUR, CHF, MXN
    UCITS Compliant Yes
    Domicile Ireland
    Investment Manager Sub-Investment Manager Fund Umbrella Replication Method Distribution Frequency PEA Eligible ISA Eligible
    State Street Global Advisors Limited State Street Global Advisors GmbH (Poland Branch) SSGA SPDR ETFs Europe II plc Replicated - No Yes
    Investment Manager State Street Global Advisors Limited
    Sub-Investment Manager State Street Global Advisors GmbH (Poland Branch)
    Fund Umbrella SSGA SPDR ETFs Europe II plc
    Replication Method Replicated
    Distribution Frequency -
    PEA Eligible No
    ISA Eligible Yes
    SIPP Eligible UK Reporting Status Securities Lending
    Yes Yes Yes
    SIPP Eligible Yes
    UK Reporting Status Yes
    Securities Lending Yes

    Listing and Ticker Information as of 16 Apr 2021

    Listing and Ticker Information as of 16 Apr 2021

    Exchange Euronext Paris (Primary)
    Trading Currency EUR
    Listing Date 08 Dec 2014
    Exchange Ticker STW
    SEDOL Code BM67JF6
    Bloomberg Code STW FP
    Reuters Code STW.PA
    Exchange SIX Swiss Exchange
    Trading Currency CHF
    Listing Date 09 Dec 2014
    Exchange Ticker STWX
    SEDOL Code BM67JH8
    Bloomberg Code STWX SE
    Reuters Code STWX.S
    Exchange Deutsche Börse
    Trading Currency EUR
    Listing Date 09 Dec 2014
    Exchange Ticker SPYH
    SEDOL Code BKX4075
    Bloomberg Code SPYH GY
    Reuters Code SPYH.DE
    Exchange London Stock Exchange
    Trading Currency EUR
    Listing Date 09 Dec 2014
    Exchange Ticker HLTH
    SEDOL Code BSBNC41
    Bloomberg Code HLTH LN
    Reuters Code HLTH.L
    Exchange Borsa Italiana
    Trading Currency EUR
    Listing Date 10 Dec 2014
    Exchange Ticker STWX
    SEDOL Code BM67JG7
    Bloomberg Code STWX IM
    Reuters Code STWX.MI
    Exchange Bolsa Mexicana de Valores
    Trading Currency MXN
    Listing Date 12 Feb 2019
    Exchange Ticker HLTHN
    SEDOL Code BJCWGN1
    Bloomberg Code HLTHN MM
    Reuters Code HLTHN.MX
    Exchange Trading Currency Listing Date Exchange Ticker SEDOL Code Bloomberg Code Reuters Code
    Euronext Paris (Primary) EUR 08 Dec 2014 STW BM67JF6 STW FP STW.PA
    SIX Swiss Exchange CHF 09 Dec 2014 STWX BM67JH8 STWX SE STWX.S
    Deutsche Börse EUR 09 Dec 2014 SPYH BKX4075 SPYH GY SPYH.DE
    London Stock Exchange EUR 09 Dec 2014 HLTH BSBNC41 HLTH LN HLTH.L
    Borsa Italiana EUR 10 Dec 2014 STWX BM67JG7 STWX IM STWX.MI
    Bolsa Mexicana de Valores MXN 12 Feb 2019 HLTHN BJCWGN1 HLTHN MM HLTHN.MX

    INAV

    INAV

    Estimated NAV per Unit at 4PM, Hong Kong as of Estimated NAV per Unit as of (Updated every 15 seconds)
    As of (Updated every 15 seconds)
    INAV TICKER CURRENCY INAV
    Estimated NAV per Unit at 4PM, Hong Kong as of
    Estimated NAV per Unit as of (Updated every 15 seconds)
    As of (Updated every 15 seconds)
    INAV TICKER
    CURRENCY
    INAV

    The Indicative NAV per share should not be viewed as the actual NAV per share. The Indicative NAV per share is provided for reference purposes only and may differ from the actual NAV per share calculated in accordance with the Prospectus.

    Fund Characteristics as of 15 Apr 2021

    Fund Characteristics as of 15 Apr 2021
    Average Market Cap (M) Number of Holdings Average Price/Book Price/Earnings Ratio FY1
    €94 594,20 M 42 4,06 17,78
    Average Market Cap (M) €94 594,20 M
    Number of Holdings 42
    Average Price/Book 4,06
    Price/Earnings Ratio FY1 17,78

    Index Characteristics as of 15 Apr 2021

    Index Characteristics as of 15 Apr 2021
    Index Dividend Yield

    This measures the weighted average of gross dividend Yield of stocks, in the index.
    2,53%
    Index Dividend Yield

    This measures the weighted average of gross dividend Yield of stocks, in the index.

    		 2,53%

    Fund Market Price as of 16 Apr 2021

    Fund Market Price as of 16 Apr 2021
    Bid Price Offer Price Closing Price Bid/Offer Spread Day High Day Low 52 Week High
    €132,20 €162,10 €161,62 €29,90 €161,62 €160,84 €170,60
    Bid Price €132,20
    Offer Price €162,10
    Closing Price €161,62
    Bid/Offer Spread €29,90
    Day High €161,62
    Day Low €160,84
    52 Week High €170,60
    52 Week Low
    €146,38
    52 Week Low €146,38

    Fund Net Asset Value as of 16 Apr 2021

    Fund Net Asset Value as of 16 Apr 2021
    NAV EUR (Official NAV) NAV CHF NAV GBP NAV MXN Assets Under Management Shares in Issue
    €161,68 CHF 177,99 £140,15 MXN $3 857,02 €444,21 M 2 747 500
    NAV EUR (Official NAV) €161,68
    NAV CHF CHF 177,99
    NAV GBP £140,15
    NAV MXN MXN $3 857,02
    Assets Under Management €444,21 M
    Shares in Issue 2 747 500
    Most Recent NAV/NAV History

    Reference NAVs are calculated for information purposes only. No warranty is provided as to the accuracy of reference NAVs. Reference NAVs are calculated with WM1600 FX (London time) rate applied in the currency indicated.

    Fund Performance

    Fund Performance

    • Fund Inception Date: 05 Dec 2014
    • Index Inception Date: 07 May 2020
    • Performance Inception Date: 30 Sep 2001
    Cumulative Annualised Calendar
    Month End

    as of 31 Mar 2021

    As Of 1 Month 3 Month YTD 1 Year 3 Year 5 Year Since Inception
    30 Sep 2001
    Fund Net 31 Mar 2021 4,36% 1,75% 1,75% 7,36% 37,46% 37,35% 177,39%
    Difference 31 Mar 2021 0,02% -0,02% -0,02% 0,01% -0,53% -0,84% -14,77%
    Fund Gross 31 Mar 2021 4,39% 1,82% 1,82% 7,67% 38,69% 39,42% 199,27%
    Difference 31 Mar 2021 0,04% 0,05% 0,05% 0,33% 0,70% 1,22% 7,10%
    Index
    MSCI Europe Health Care 35/20 Capped Index
    		 31 Mar 2021 4,35% 1,77% 1,77% 7,34% 37,99% 38,19% 192,17%
    Month End

    as of 31 Mar 2021

    As Of 1 Month 3 Month YTD 1 Year 3 Year 5 Year Since Inception
    30 Sep 2001
    Fund Net 31 Mar 2021 4,36% 1,75% 1,75% 7,36% 11,18% 6,55% 5,37%
    Difference 31 Mar 2021 0,02% -0,02% -0,02% 0,01% -0,14% -0,13% -0,28%
    Fund Gross 31 Mar 2021 4,39% 1,82% 1,82% 7,67% 11,52% 6,87% 5,78%
    Difference 31 Mar 2021 0,04% 0,05% 0,05% 0,33% 0,19% 0,19% 0,13%
    Index
    MSCI Europe Health Care 35/20 Capped Index
    		 31 Mar 2021 4,35% 1,77% 1,77% 7,34% 11,33% 6,68% 5,65%

    as of 31 Mar 2021

    2021 (YTD) 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
    Fund Net 1,75% -2,05% 31,62% -0,70% 2,75% -9,49% 14,77% 19,11% 25,31% 17,69% 13,64%
    Difference -0,02% -0,15% -0,15% -0,12% -0,12% -0,11% -0,26% -0,17% -0,29% -0,19% -0,12%
    Fund Gross 1,82% -1,76% 32,02% -0,40% 3,05% -9,22% 15,12% 19,47% 25,68% 18,04% 13,98%
    Difference 0,05% 0,15% 0,24% 0,18% 0,19% 0,16% 0,09% 0,19% 0,09% 0,16% 0,22%
    Index
    MSCI Europe Health Care 35/20 Capped Index
    		 1,77% -1,90% 31,77% -0,58% 2,86% -9,38% 15,03% 19,28% 25,59% 17,88% 13,76%

    Performance Gross and Net of All Fees.

    Capital Risk: Investing involves risk including the risk of loss of capital.

    Past performance is not a guarantee of future results.

    Past performance is not an indicator of future performance. The Gross of fees do not reflect and net of fees do reflect commissions and costs incurred on the issue and redemption, or purchases and sale, of units. If the performance is calculated on the basis of Gross/net asset values that are not denominated in the accounting currency of the collective investment scheme, its value may rise or fall as a result of currency fluctuations.

    Calendar year inception performance returns will be partial for the year where the inception date for either the Fund in question or the historic performance-linked Fund (whichever is the earliest) falls within that period.

    Deviation & Tracking Error as of 31 Mar 2021

    Deviation & Tracking Error as of 31 Mar 2021

    Standard Deviation Tracking Error
    12,62% 0,15%
    Standard Deviation 12,62%
    Tracking Error 0,15%

    This calculation is based on the past 3 years performance information.

    Top Holdings

    Top Holdings
    Fund Top Holdingsas of 15 Apr 2021

    Fund Top Holdings as of 15 Apr 2021

    Security Name Weight
    Roche Holding Ltd 16,32%
    Novartis AG 13,42%
    AstraZeneca PLC 9,27%
    Novo Nordisk A/S Class B 8,57%
    Sanofi 7,94%
    GlaxoSmithKline plc 6,46%
    Bayer AG 4,30%
    Koninklijke Philips N.V. 3,81%
    Lonza Group AG 3,14%
    Alcon Inc. 2,52%
    Download All Holdings: Download Daily Holdings

    Industry Allocation

    Industry Allocation
    Fund Industry Allocationas of 15 Apr 2021

    Fund Industry Allocation as of 15 Apr 2021

    Sector Weight
    Pharmaceuticals 71,46%
    Health Care Equipment & Supplies 16,20%
    Life Sciences Tools & Services 5,82%
    Health Care Providers & Services 3,27%
    Biotechnology 3,25%

    Geographical Weights

    Geographical Weights
    Fund Documents
    Information & Schedules

    Fund Footnote

    Characteristics, holdings and sectors shown are as of the date indicated and are subject to change. This information should not be considered a recommendation to invest in a particular sector or to buy or sell any security shown. It is not known whether the sectors or securities shown will be profitable in the future. The holdings are taken from the accounting records of SSGA which may differ from the official books and records of the custodian.

    Performance Gross and Net of All Fees.

    Capital Risk: Investing involves risk including the risk of loss of capital.

    Past performance is not a guarantee of future results.

    Past performance is not an indicator of future performance. The Gross of fees do not reflect and net of fees do reflect commissions and costs incurred on the issue and redemption, or purchases and sale, of units. If the performance is calculated on the basis of Gross/net asset values that are not denominated in the accounting currency of the collective investment scheme, its value may rise or fall as a result of currency fluctuations.

    First net asset value taken into account corresponds to the first end of month following complete investment of the portfolio in agreement with the policy of management. Historical performance is not necessarily indicative of actual future investment performance.

    The financial products referred to herein are not sponsored, endorsed, or promoted by MSCI and MSCI bears no liability with respect to any such financial products or any index on which such financial products are based. The Prospectus contains a more detailed description of the limited relationship MSCI has with SSGA and any related financial products.

    Previous to 1 December 2020, this Fund's Benchmark was the MSCI Europe Health Care Index.

    Important Risk Information:

     

    SPDR ETF is the exchange traded funds ("ETF") platform of State Street Global Advisors and is comprised of funds that have been authorised by European regulatory authorities as open-ended UCITS investment companies. SPDR ETFs may not be available or suitable for you.

     

    ETFs trade like stocks, are subject to investment risk, fluctuate in market value and may trade at prices above or below the ETFs net asset value. Brokerage commissions and ETF expenses will reduce returns.

     

    Changes in exchange rates may have an adverse effect on the value, price or income of an investment. Further, there is no guarantee an ETF will achieve its investment objective.

     

    SHARES IN THE FUNDS OF THE SPDR® ETF SICAV, SSGA SPDR ETFS EUROPE I AND SSGA SPDR ETFS EUROPE II PLC MAY NOT BE AVAILABLE FOR OR SUITABLE FOR YOU. THE VIEWS EXPRESSED IN THIS SITE DO NOT CONSTITUTE INVESTMENT ADVICE. INDEPENDENT ADVICE SHOULD BE SOUGHT IN CASES OF DOUBT. NEITHER THE INFORMATION NOR ANY OPINION CONTAINED ON THIS SITE CONSTITUTES A SOLICITATION OR OFFER TO BUY OR SELL SHARES OF THE FUNDS OR ANY OTHER FINANCIAL INSTRUMENT.

     

    Standard & Poor's®, S&P® and SPDR® are registered trademarks of Standard & Poor's Financial Services LLC (S&P); Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC (Dow Jones); and these trademarks have been licensed for use by S&P Dow Jones Indices LLC (SPDJI) and sublicensed for certain purposes by State Street Corporation. State Street Corporation's financial products are not sponsored, endorsed, sold or promoted by SPDJI, Dow Jones, S&P, their respective affiliates and third party licensors and none of such parties make any representation regarding the advisability of investing in such product(s) nor do they have any liability in relation thereto, including for any errors, omissions, or interruptions of any index.

     

    SPDR ETFs may be offered and sold only in those jurisdictions where authorised, in compliance with applicable regulations.

     

    Information related to Mexico

     

    This information does not constitute and is not intended to constitute marketing or an offer of securities and accordingly should not be construed as such. The Funds referenced herein have not been, and will not be, registered under the Mexican Securities Market Law (Ley del Mercado de Valores) and may not be publicly offered or sold in the United Mexican States. Disclosure documentation related to any of the aforementioned Funds may not be distributed publicly in Mexico and shares of the Funds may not be traded in Mexico.

     

    You should obtain and read a prospectus and KIID relating to the SPDR ETFs prior to investing. Further information and the prospectus/KIID describing the characteristics, costs and risks of SPDR ETFs are available for residents of countries where SPDR ETFs are authorised for sale on the SPDRs website and from your local SSGA office.

    © 2021 %%State Street Corporation%%. All rights reserved.